Risks of non-breast, non-ovarian cancers for BRCA1 and BRCA2 pathogenic variant carriers: a prospective cohort study
Apart from pancreatic, prostate, and possibly stomach cancers for BRCA2 PV carriers, and possibly pancreatic cancer for BRCA1 PV carriers, there is no evidence that BRCA1 and BRCA2 PV carriers have substantially increased risks of other non-breast, non-ovarian cancers. Our prospective risk estimates are informative for cancer risk assessment for people with BRCA1 and BRCA2 PVs.
Authors
- R. Yang
- J Hopper
- E. F. Ross
- Shuai Li (ORCID: https://orcid.org/0000-0002-6096-6873)
- Sarah Colonna
- Whitney F. Maxwell
- K. Phillips
- R L Milne
- Tu Nguyen-Dumont
- Jeanine M. Genkinger
- Melissa C. Southey
- Mary Beth Terry
- Esther M. John
- Mary Daly
- Irene L. Andrulis
- Allison W. Kurian
- Robert J. MacInnis
Institutions
- Fox Chase Cancer Center (US)
- The University of Melbourne (AU)
- University of Toronto (CA)
- Cancer Council Victoria (AU)
- Peking University (CN)
- Lunenfeld-Tanenbaum Research Institute (CA)
- University of Utah (US)
- Columbia University Irving Medical Center (US)
- Peter MacCallum Cancer Centre (AU)
- Huntsman Cancer Institute (US)
- Silent Spring Institute (US)
- Monash Health (AU)
- Temple University Health System (US)
- Sinai Health System (CA)
- Monash University (AU)
- Columbia University (US)
- Stanford University (US)
Publication Details
- Journal
- BMC Medicine
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1186/s12916-026-04753-8
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00